3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Lymphoid
1
Conditions
Lymphoma
41
Lymphoma, Large B-Cell, Diffuse
31
Lymphoma, Non-Hodgkin
28
Lymphoma, Follicular
21
Lymphoma, Large-Cell, Immunoblastic
17
Hodgkin Disease
16
Lymphoma, Mantle-Cell
15
Burkitt Lymphoma
14
Precursor Cell Lymphoblastic Leukemia-Lymphoma
11
Leukemia, Lymphocytic, Chronic, B-Cell
9
Recurrence
8
Lymphoma, Large-Cell, Anaplastic
8
Lymphoma, B-Cell, Marginal Zone
6
Waldenstrom Macroglobulinemia
5
Lymphoma, B-Cell
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Neoplasms
4
Lymphoma, Extranodal NK-T-Cell
4
Immunoblastic Lymphadenopathy
4
Neoplasm Metastasis
3
Lymphoma, T-Cell, Peripheral
3
Lymphoma, T-Cell, Cutaneous
3
Mesothelioma
2
Lymphoma, T-Cell
2
Leukemia
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms
2
Uveal Melanoma
1
Sezary Syndrome
1
Primary Myelofibrosis
1
Interventions
Etoposide
4
pegaspargase
3
Cyclophosphamide
3
Methylprednisolone
2
Gemcitabine
2
Flow Cytometry
2
Dexamethasone
2
Alemtuzumab
2
zanubrutinib
1
sintilimab
1
ruxolitinib
1
fludarabine phosphate
1
fludarabine
1
Whole-Body Irradiation
1
Vincristine
1
Thiotepa
1
Th1-Th2 Balance
1
Tacrolimus
1
Rituximab
1
Prednisone
1
Polymerase Chain Reaction
1
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
1
Methylprednisolone Hemisuccinate
1
Melphalan
1
In Situ Hybridization
1
Immunohistochemistry
1
EPOCH protocol
1
Doxorubicin
1
Cytogenetic Analysis
1
Cytarabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lymphohistiocytosis, Hemophagocytic
×
Cisplatin
×
Lymphoid
×
Clear all
NCT04999878
2021-08-11
RUE-DDGP
Zhengzhou University
Phase 4
Unknown
30 enrolled